Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E de Jonge

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Methods of Information in Medicine|May 12, 2007
Modeling length of stay as an optimized two-class prediction problemMarion Verduijn, N Peek, V Voorbraak, et al.
British Journal of Clinical Pharmacology|March 9, 2005
Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor ELMilly E de Jonge, Alwin Dr Huitema, Jan Hm Schellens, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Understanding rising caesarean section trends: relevance of inductions and prelabour obstetric interventions at termA Thaens, A Bonnaerens, G Martens, et al.
Infection and Immunity|March 20, 2001
Induction of cell-associated chemokines after endotoxin administration to healthy humansD P Olszyna, E De Jonge, P E Dekkers, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2005
Significant induction of cyclophosphamide and thiotepa metabolism by phenytoinMilly E de Jonge, Alwin D R Huitema, Selma M van Dam, et al.
Anti-Cancer Drugs|February 16, 2005
Effects of co-medicated drugs on cyclophosphamide bioactivation in human liver microsomesMilly E de Jonge, Alwin D R Huitema, Selma M van Dam, et al.
Intensive Care Medicine|June 23, 2006
Short-term and long-term mortality in very elderly patients admitted to an intensive care unitS E de Rooij, A Govers, J C Korevaar, et al.
Therapeutic Drug Monitoring|November 25, 2005
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and CarboplatinMilly E de Jonge, Alwin D R Huitema, Selma M van Dam, et al.
Methods of Information in Medicine|July 10, 2012
Statistical process control for monitoring standardized mortality ratios of a classification tree modelLilian Minne, S Eslami, N de Keizer, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatinMilly E De Jonge, Ron A A Mathôt, Selma M Van Dam, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Methods of Information in Medicine|May 12, 2007
Modeling length of stay as an optimized two-class prediction problemMarion Verduijn, N Peek, V Voorbraak, et al.
British Journal of Clinical Pharmacology|March 9, 2005
Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor ELMilly E de Jonge, Alwin Dr Huitema, Jan Hm Schellens, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Understanding rising caesarean section trends: relevance of inductions and prelabour obstetric interventions at termA Thaens, A Bonnaerens, G Martens, et al.
Infection and Immunity|March 20, 2001
Induction of cell-associated chemokines after endotoxin administration to healthy humansD P Olszyna, E De Jonge, P E Dekkers, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2005
Significant induction of cyclophosphamide and thiotepa metabolism by phenytoinMilly E de Jonge, Alwin D R Huitema, Selma M van Dam, et al.
Anti-Cancer Drugs|February 16, 2005
Effects of co-medicated drugs on cyclophosphamide bioactivation in human liver microsomesMilly E de Jonge, Alwin D R Huitema, Selma M van Dam, et al.
Intensive Care Medicine|June 23, 2006
Short-term and long-term mortality in very elderly patients admitted to an intensive care unitS E de Rooij, A Govers, J C Korevaar, et al.
Therapeutic Drug Monitoring|November 25, 2005
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and CarboplatinMilly E de Jonge, Alwin D R Huitema, Selma M van Dam, et al.
Methods of Information in Medicine|July 10, 2012
Statistical process control for monitoring standardized mortality ratios of a classification tree modelLilian Minne, S Eslami, N de Keizer, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatinMilly E De Jonge, Ron A A Mathôt, Selma M Van Dam, et al.
Pageof 13